Status:

RECRUITING

CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

Lead Sponsor:

University of Wisconsin, Madison

Collaborating Sponsors:

Veloxis Pharmaceuticals

Conditions:

Kidney Pancreas Transplantation

Eligibility:

All Genders

18-70 years

Phase:

PHASE2

PHASE3

Brief Summary

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 20 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years pri...

Detailed Description

Accrual objective: Enrollment of 2-3 participants per month and all participants within an 18 month period. With minimum of 1 year follow-up post-conversion, we anticipate the entire study would be co...

Eligibility Criteria

Inclusion

  • Adult, 18-70 years of age
  • Participant must be able to understand and provide consent
  • History of Diabetes Type 1 or Insulin-Dependent Diabetes Type 2 with Chronic Kidney Disease (CKD)
  • Recipient of a Simultaneous Pancreas Kidney (SPK) transplant, 3- 60 months prior to screening, per Principal Investigator's discretion.
  • Have a history of tremors following transplantation
  • Stable pancreas allograft function as evidenced by no requirement of exogenous insulin or oral anti-diabetic agents and stable pancreatic enzymes
  • Stable kidney allograft function
  • Currently taking Immediate-Release (IR) tacrolimus
  • Women of child-bearing potential (WOCP) must have a negative pregnancy test at the time of study entry

Exclusion

  • Currently maintained on an extended-release tacrolimus immunosuppressive regimen
  • Previous history of tremors prior to transplantation
  • Solitary pancreas transplant recipients
  • History of solid organ transplant other than a kidney or pancreas
  • Uncontrolled concomitant infection at the discretion of the investigator
  • Presence of Donor Specific Antibodies

Key Trial Info

Start Date :

February 27 2019

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2026

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT03769298

Start Date

February 27 2019

End Date

December 1 2026

Last Update

April 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Wisconsin

Madison, Wisconsin, United States, 53792